Cargando…
Impact of UGT2B7 (His268Tyr )polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer
INTRODUCTION: Epirubicin is a common adjuvant treatment for breast cancer. It is mainly eliminated after glucuronidation through uridine diphosphate-glucuronosyltransferase 2B7 (UGT2B7). The present study aimed to describe the impact of the UGT2B7(His268Tyr )polymorphism on invasive disease-free sur...
Autores principales: | Parmar, Sumit, Stingl, Julia Carolin, Huber-Wechselberger, Ariana, Kainz, Alexander, Renner, Wilfried, Langsenlehner, Uwe, Krippl, Peter, Brockmöller, Jürgen, Haschke-Becher, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218946/ https://www.ncbi.nlm.nih.gov/pubmed/21658222 http://dx.doi.org/10.1186/bcr2894 |
Ejemplares similares
-
A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival
por: Hofmann, Guenter, et al.
Publicado: (2009) -
Kallmann syndrome with a Tyr113His PROKR2 mutation
por: Ha, Jeong-Ha, et al.
Publicado: (2017) -
BCL2 genotypes and prostate cancer survival
por: Renner, Wilfried, et al.
Publicado: (2017) -
mEH Tyr113His polymorphism and the risk of ovarian cancer development
por: Zhong, Jian-Hong, et al.
Publicado: (2013) -
Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia
por: Ziskin, Jennifer L., et al.
Publicado: (2015)